JONATHAN MIZGALA: Open Payments
NPI 1164968434 · ILION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 39 payments from 6 companies in 2025. Trend: 2023 $259 · 2024 $164 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $160 |
| Neurocrine BioSciences, Inc. | 3 | $107 |
| Janssen Pharmaceuticals, Inc | 3 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| ACADIA Pharmaceuticals Inc | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
Products named: AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, NUPLAZID, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, UZEDY.
Industry payments across NY — which companies pay providers there.
